Identification and characterization of T cell-stimulating antigens from Leishmania by CD4 T cell expression cloning

Journal of Immunology

Volumn 166, Issue 1, 2001, Pages 498-505

  Probst, P ^a   Stromberg, E ^a   Ghalib, H W ^a   Mozel, M ^a   Badaro, R ^a   Reed, S G ^a   Webb, J R ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; BETA TUBULIN; CD4 ANTIGEN; ELONGATION FACTOR 2; HISTONE H2B; MALATE DEHYDROGENASE; RIBOSOME PROTEIN;

ARTICLE; CELL CLONE; CLINICAL ARTICLE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; LEISHMANIA; LEISHMANIA MAJOR; LEISHMANIASIS; LYMPHOCYTE ACTIVATION; NUCLEOTIDE SEQUENCE; PARASITE IMMUNITY; PHENOTYPE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; T LYMPHOCYTE;

EID: 0035160528     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.1.498     Document Type: Article

References (38)

1. Leishmaniasis
2. Regulator and effector functions of T-cell subsets in human Leishmania infections
3. Clinical spectrum of Leishmaniasis
4. Control of the leishmaniases: Report of a WHO expert committee
5. Epidemic visceral leishmaniasis in southern Sudan: Treatment of severely debilitated patients under wartime conditions and with limited resources
6. Experimental leishmaniasis in humans: Review
7. + T cells in leishmaniasis
8. The regulation of immunity to Leishmanta major
9. Leishmania and HIV coinfection: The first 10 years
10. Experiences with vaccines against cutaneous leishmaniasis: Of men and mice
11. Recent trends in vaccine development and immunization
12. Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes
13. Leishmania major: Production of recombinant gp63, its antigenicity and immunogenicity in mice
14. Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune response
15. Membrane glycoprotein M-2 protects against Leishmania amazonensis infection
16. Expression cloning of a protective Leishmania antigen
17. Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis
18. New perspectives on a subclinical form of visceral leishmaniasis
19. A prospective study of visceral leishmaniasis in an endemic area of Brazil
20. An analysis of T cell responsiveness in Indian kala-azar
21. + T cells
22. Human and murine immune responses to a novel Leishmania major recombinant protein encoded by members of a multicopy gene family
23. A Leishmania protein that modulates interleukin (IL)-12, IL-10 and tumor necrosis factor α production and expression of B7-1 in human monocyte-derived antigen-presenting cells
24. TH2-type infiltrating T cells in nickel-induced contact dermatitis
25. Molecular characterization of the heat-inducible LmSTII protein of Leishmania major
26. Molecular cloning of the glycosomal malate dehydrogenase of Trypanosoma brucei
27. Structure and regulation of histone H2B mRNAs from Leishmania enriettii
28. Differential expression of Leishmania major β-tubulin genes during the acquisition of promastigote infectivity
29. A physical map of the Leishmania major Friedlin genome
30. Purification of particulate malate dehydrogenase and phosphoenolpyruvate carboxykinase from Leishmania mexicana
31. Biology of Leishmania and leishmaniasis
32. Histone genes in trypanosomatids
33. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages
34. Antigen presentation by Leishmania mexicana-infected macrophages: Activation of helper T cells specific for amastigote cysteine proteinases requires intracellular killing of the parasites
35. Antigenicity of the Leishmania infantum histones H2B and H4 during canine viscerocutaneous leishmaniasis
36. Analysis of the humoral immune response against total and recombinant antigens of Leishmania infantum: Correlation with disease progression in canine experimental leishmaniasis
37. Susceptibility to infectious diseases: Leishmania as a paradigm
38. Antigen presentation by macrophages harboring intravesicular pathogens